528 related articles for article (PubMed ID: 16048445)
1. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
2. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of insight for suicide, violence, hospitalization, and social adjustment for outpatients with schizophrenia: a prospective study.
Yen CF; Yeh ML; Chen CS; Chung HH
Compr Psychiatry; 2002; 43(6):443-7. PubMed ID: 12439831
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
5. Changes of insight in manic episodes and influencing factors.
Yen CF; Chen CS; Yeh ML; Yang SJ; Ke JH; Yen JY
Compr Psychiatry; 2003; 44(5):404-8. PubMed ID: 14505301
[TBL] [Abstract][Full Text] [Related]
6. Relationships between insight and psychosocial adjustment in patients with bipolar I disorder.
Yen CF; Chen CS; Yang SJ; Ko CH; Yen JY; Huang CF
Bipolar Disord; 2007 Nov; 9(7):737-42. PubMed ID: 17988364
[TBL] [Abstract][Full Text] [Related]
7. The predictive effect of insight on adverse clinical outcomes in bipolar I disorder: a two-year prospective study.
Yen CF; Chen CS; Yen JY; Ko CH
J Affect Disord; 2008 May; 108(1-2):121-7. PubMed ID: 17997489
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of insight in schizophrenia, bipolar I disorder, and depressive disorders with and without comorbid alcohol use disorder.
Yen CF; Chen CC; Cheng CP; Yen CN; Lin HC; Ko CH; Yen JY; Chen CS
Psychiatry Clin Neurosci; 2008 Dec; 62(6):685-90. PubMed ID: 19068005
[TBL] [Abstract][Full Text] [Related]
9. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
10. [Bipolar episodes in adolescents: diagnostic issues and follow-up in adulthood].
Cohen D; Guilé JM; Brunelle J; Bodeau N; Louët E; Lucanto R; Consoli A
Encephale; 2009 Dec; 35 Suppl 6():S224-30. PubMed ID: 20141776
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up.
de Haan L; van Amelsvoort T; Dingemans P; Linszen D
Pharmacopsychiatry; 2007 Nov; 40(6):264-8. PubMed ID: 18030650
[TBL] [Abstract][Full Text] [Related]
12. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
13. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders.
Yen CF; Lee Y; Tang TC; Yen JY; Ko CH; Chen CC
J Nerv Ment Dis; 2009 Mar; 197(3):172-7. PubMed ID: 19282683
[TBL] [Abstract][Full Text] [Related]
15. Relationship between insight and neurocognition in patients with bipolar I disorder in remission.
Yen CF; Cheng CP; Ko CH; Yen JY; Huang CF; Chen CS
Compr Psychiatry; 2008; 49(4):335-9. PubMed ID: 18555052
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
[TBL] [Abstract][Full Text] [Related]
17. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
[TBL] [Abstract][Full Text] [Related]
18. Relationship between psychosocial adjustment and executive function in patients with bipolar disorder and schizophrenia in remission: the mediating and moderating effects of insight.
Yen CF; Cheng CP; Huang CF; Ko CH; Yen JY; Chang YP; Chen CS
Bipolar Disord; 2009 Mar; 11(2):190-7. PubMed ID: 19267701
[TBL] [Abstract][Full Text] [Related]
19. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
Wong MM; Chen EY; Lui SS; Tso S
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
[TBL] [Abstract][Full Text] [Related]
20. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study.
Yamada K; Watanabe K; Nemoto N; Fujita H; Chikaraishi C; Yamauchi K; Yagi G; Asai M; Kanba S
Psychiatry Res; 2006 Jan; 141(1):61-9. PubMed ID: 16318875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
